Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

van der Heijde, Desiree   •   Dijkmans, Ben   •   Geusens, Piet   •   Sieper, Joachim   •   DeWoody, Kimberly   •   Williamson, Paul   •   Braun, Jurgen

published in: Arthritis and rheumatism



endpoint

Infliximab has (optional: compared with placebo) proved to be better.
complication rate fewer


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection
conservative therapy → injection therapy

publication details

10.1002/art.20852
pubmed
15692973
2005
journal
randomized controlled trial
yes
prospective
1+